CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 169 filers reported holding CARDLYTICS INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,217,500 | +244.0% | 195,000 | +31.8% | 8.24% | +211.5% |
| Q2 2023 | $935,360 | -65.4% | 148,000 | -48.6% | 2.64% | -40.9% |
| Q3 2022 | $2,707,000 | +16.9% | 288,000 | +177.5% | 4.47% | -28.6% |
| Q2 2022 | $2,316,000 | -32.8% | 103,800 | +65.6% | 6.26% | +55.0% |
| Q1 2022 | $3,447,000 | -31.8% | 62,700 | -18.0% | 4.04% | -27.4% |
| Q4 2021 | $5,056,000 | -68.3% | 76,500 | -59.7% | 5.57% | -24.5% |
| Q3 2021 | $15,932,000 | -24.7% | 189,800 | +13.9% | 7.37% | +57.3% |
| Q2 2021 | $21,159,000 | +4.6% | 166,700 | -9.6% | 4.69% | -4.8% |
| Q1 2021 | $20,229,000 | -11.9% | 184,400 | +14.6% | 4.92% | +25.4% |
| Q4 2020 | $22,972,000 | +81.4% | 160,900 | -10.4% | 3.93% | -11.4% |
| Q3 2020 | $12,667,000 | +453.4% | 179,500 | +174.1% | 4.43% | -28.1% |
| Q1 2020 | $2,289,000 | – | 65,477 | – | 6.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |